Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-05

Clinical Trial Update: Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating pregnenolone and L-theanine augmentation for schizophrenia and schizoaffective disorder. The sponsor is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-theanine (L-theanine)
  • Pregnenolone (pregnenolone)

Snippet

Sponsor: Sha'ar Menashe Mental Health Center | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: UNKNOWN